Effect of intravenous alfacalcidol on lymphocyte phenotyping in hemodialysis patients

American Journal of Kidney Diseases

Volumn 32, Issue 6, 1998, Pages 1036-1040

  Huraib, S ^a   Tanimu, D ^a   Abu Romeh, S ^a   Al Khairy, K ^a   Quadri, K ^a   Al Ghamdi, G ^a   Iqbal, A ^a  

^a KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

Alfacalcidol; Hemodialysis; Lymphocyte; Natural killer cell; Phenotyping

Indexed keywords

ALFACALCIDOL; CD19 ANTIGEN; CD2 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; VITAMIN D;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE;

EID: 0031797902     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(98)70080-0     Document Type: Article

References (35)